MCH ANALYSIS RESEARCHMain site ↗
Real Estate

Retail REITs

8 companies under coverage.

Coverage

Retail REITs


Equity Research

Agree Realty Corporation (ADC)

BUY. 12-month probability-weighted target $82 (+25% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

ADCEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +20.8%
Equity Research

Brixmor Property (BRX)

BUY. 12-month probability-weighted target $33 (+20% vs spot). P/E Multiple explains 88% of Monte Carlo outcome variance.

BRXEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +16.4%
Equity Research

Kite Realty Group Trust (KRG)

BUY. 12-month probability-weighted target $30 (+25% vs spot). P/E Multiple explains 90% of Monte Carlo outcome variance.

KRGEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +16.1%
Equity Research

NNN REIT, Inc. (NNN)

BUY. 12-month probability-weighted target $48 (+19% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

NNNEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +15.8%
Equity Research

Realty Income Corporation (O)

BUY. 12-month probability-weighted target $63 (+17% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

OEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +14.7%
Equity Research

Regency Centers Corporation (REG)

HOLD. 12-month probability-weighted target $82 (+14% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

REGEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +10.2%
Equity Research

Simon Property Group Inc (SPG)

BUY. 12-month probability-weighted target $232 (+17% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

SPGEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +5.2%
Equity Research

Federal Realty Investment Trust (FRT)

Rating suspended since 2026-10-01 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

FRTEquity ResearchMonte Carlo
1 October 2026Rating: N/A
MCH ANALYSIS · All research · Research, not personal financial advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed

MCH Analysis is a general investment-research publication of MCH Advisory (Pty) Ltd. It is not personal financial advice and does not take your circumstances into account. MCH is not a licensed financial services provider or a registered investment adviser. Past performance, whether actual or simulated, does not predict future results. Subscriber Agreement | Privacy and Cookie Notice | Research Governance Policies